Oxidants and antioxidants in atherosclerosis

被引：90

作者：

Mashima, R ^{[1
]}

Witting, PK ^{[1
]}

Stocker, R ^{[1
]}

机构：

[1] Heart Res Inst, Biochem Grp, Camperdown, NSW 2050, Australia

来源：

CURRENT OPINION IN LIPIDOLOGY | 2001年 / 12卷 / 04期

关键词：

D O I：

10.1097/00041433-200108000-00007

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The oxidative theory suggests that LDL oxidation contributes to atherogenesis, implying that attenuation of this process by antioxidants should decrease atherosclerosis. However, a causative link between LDL oxidation and atherogenesis is not firmly established. It requires the identification of the oxidants that are responsible for the initiation of LDL oxidation, and an understanding of the modified moieties that are responsible for the proatherogenic activities of oxidized LDL. The present review summarizes recent data on potential biological oxidants for LDL in the vessel wall, and discusses the antiatherogenic role(s) of selected antioxidants. Curr Coin Lipidol 12:411-418. (C) 2001 Lippincott Williams & Wilkins.

引用

页码：411 / 418

页数：8

共 105 条

[1] HETEROLYTIC VERSUS HOMOLYTIC PEROXIDE BOND-CLEAVAGE BY SPERM WHALE MYOGLOBIN AND MYOGLOBIN MUTANTS [J].

ALLENTOFF, AJ ;

BOLTON, JL ;

WILKS, A ;

THOMPSON, JA ;

DEMONTELLANO, PRO .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (25) :9744-9749

[2] Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein - A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation [J].

Anderson, MM ;

Hazen, SL ;

Hsu, FF ;

Heinecke, JW .

JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (03) :424-432

[3] THE EFFECT OF CHOLESTEROL-LOWERING AND ANTIOXIDANT THERAPY ON ENDOTHELIUM-DEPENDENT CORONARY VASOMOTION [J].

ANDERSON, TJ ;

MEREDITH, IT ;

YEUNG, AC ;

FREI, B ;

SELWYN, AP ;

GANZ, P .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (08) :488-493

[4] Specific cellular responses to α-tocopherol [J].

Azzi, A ;

Breyer, I ;

Feher, M ;

Pastori, M ;

Ricciarelli, R ;

Spycher, S ;

Staffieri, M ;

Stocker, A ;

Zimmer, S ;

Zingg, JM .

JOURNAL OF NUTRITION, 2000, 130 (07) :1649-1652

[5] APPARENT HYDROXYL RADICAL PRODUCTION BY PEROXYNITRITE - IMPLICATIONS FOR ENDOTHELIAL INJURY FROM NITRIC-OXIDE AND SUPEROXIDE [J].

BECKMAN, JS ;

BECKMAN, TW ;

CHEN, J ;

MARSHALL, PA ;

FREEMAN, BA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) :1620-1624

[6] Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits [J].

Behr-Roussel, D ;

Rupin, A ;

Simonet, S ;

Bonhomme, E ;

Coumailleau, S ;

Cordi, A ;

Serkiz, B ;

Fabiani, JN ;

Verbeuren, TJ .

CIRCULATION, 2000, 102 (09) :1033-1038

[7] OXYGENATION OF LIPOPROTEINS BY MAMMALIAN LIPOXYGENASES [J].

BELKNER, J ;

WIESNER, R ;

RATHMAN, J ;

BARNETT, J ;

SIGAL, E ;

KUHN, H .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 213 (01) :251-261

[8]

Bird DA, 1998, J LIPID RES, V39, P1079

[9] Evidence of hypoxic areas within the arterial wall in vivo [J].

Björnheden, T ;

Levin, M ;

Evaldsson, M ;

Wiklund, O .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (04) :870-876

[10] Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial [J].

Boaz, M ;

Smetana, S ;

Weinstein, T ;

Matas, Z ;

Gafter, U ;

Iaina, A ;

Knecht, A ;

Weissgarten, Y ;

Brunner, D ;

Fainaru, M ;

Green, MS .

LANCET, 2000, 356 (9237) :1213-1218

← 1 2 3 4 5 6 7 8 9 10 →